Burning Questions and Controversies in the Management of Advanced Prostate Cancer Patients
Scott B. Sellinger, MD, President of Advanced Urology Institute and a Partner at Southeastern Urological Center in Tallahassee, Florida, breaks down treatment groups for advanced prostate cancer and details therapeutic options for each, including additional therapeutic options beyond androgen deprivation therapy such as ARIs, APIs, and PARP inhibitors.
Read More